Recalls / Active ingredient / Polyethylene Glycol 3350
Polyethylene Glycol 3350
6 FDA drug recalls involving the active ingredient “Polyethylene Glycol 3350”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2022-06-29 | Class II | Miralax (Polyethylene Glycol 3350), Powder for Solution, Osmotic Laxative, 30 Once-Daily Doses, Net WT 17.9 OZ | Mckesson Medical-Surgical Inc. Corporate Office |
| 2022-04-27 | Class II | GaviLyte -C (Polyethylene Glycol 3350, 240 g) and electrolytes for Oral Solution, USP with flavor pack NDC# 4 | Lupin Pharmaceuticals Inc. |
| 2021-07-29 | Class II | GaviLyteTM - C PEG-3350 (240g) and Electrolytes for Oral Solution, USP with Flavor Pack Manufactured by Novel | Novel Laboratories, Inc. d.b.a LUPIN |
| 2021-03-15 | Class II | POLYETHYLENE GLYCOL 3350 Powder for Solution Osmotic Laxative 14 once-daily doses 14 Packet- Newt Wt. 0.5 oz ( | Cardinal Health Inc. |
| 2021-03-15 | Class II | Polyethylene Glycol 3350 Powder for Solution, Laxative Net Wt 4.1 oz (119 g) 7 Once-Daily Doses NDC 45802-868- | Cardinal Health Inc. |
| 2019-03-19 | Class II | Gavilyte-N, PEG-3350, Sodium chloride, Sodium Bicarbonate and Potassium Chloride for Oral Solution, Rx only, M | LUPIN SOMERSET |